Clinical Trials Browser

Phase 1/2 × mirdametinib × Sarcoma × Clear all

NCT06843967 2026-05-22

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Phase 1/2 Recruiting

Liposarcoma, Liposarcoma, Myxoid